Company registration number 07441522 (England and Wales)
TELUS HEALTH (BF) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
TELUS HEALTH (BF) LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 7
TELUS HEALTH (BF) LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
4
389,623
843,024
Cash at bank and in hand
1,808
1,408,933
391,431
2,251,957
Creditors: amounts falling due within one year
5
(8,177)
(1,996,068)
Net current assets
383,254
255,889
Capital and reserves
Called up share capital
158
158
Share premium account
1,503
1,503
Profit and loss reserves
381,593
254,228
Total equity
383,254
255,889

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 24 September 2026 and are signed on its behalf by:
Mr P J Mullen
Director
Company Registration No. 07441522
TELUS HEALTH (BF) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Telus Health (BF) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 54 Portland Place, London, W1B 1DY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

As noted in the Directors' Report the company ceased trading in May 2025. The company has sufficient resources, with the help of the parent company, to settle its liabilities as they fall due, and therefore the company will be wound up in an orderly fashion. Because of this the financial statements have been prepared on a basis other than as a going concern.true

1.3
Turnover

All significant revenue streams arise from the sale of software and licenses and maintenance and support contracts.

 

Revenue is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods and services provided in the normal course of business, net of discounts, VAT and other sales related taxes.

 

Revenue arising from the sale of services is recognised when and to the extent that the company obtains the right to consideration in exchange for the performance of its contractual obligations.

 

Revenue from software licenses and maintenance and support contracts is recognised pro-rata over the duration of the agreement, provided that there are no significant vendor obligations remaining and collectability of the debt is expected.

 

Billings in excess of revenue recognised are held in the balance sheet under "deferred revenue".

Where the company's website is expected to generate future revenues in excess of costs of developing those websites, expenditure on functionality of the website is capitalised and treated as a tangible fixed asset. Expenditure incurred on maintaining websites and expenditure incurred on developing websites used only for advertising and promotional purposes are written off as incurred.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, and other short-term liquid investments with original maturities of three months or less

TELUS HEALTH (BF) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

TELUS HEALTH (BF) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

1.11

Website development costs

Where the company's website is expected to generate future revenues in excess of costs of developing those websites, expenditure on functionality of the website is capitalised and treated as a tangible fixed asset. Expenditure incurred on maintaining websites and expenditure incurred on developing websites used only for advertising and promotional purposes are written off as incurred.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

The directors do not believe there are any critical judgements or key sources of estimation uncertainty.

TELUS HEALTH (BF) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
7
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
77,505
Corporation tax recoverable
77,780
77,780
Amounts owed by group undertakings
311,893
-
0
Other debtors
(575)
14,234
Prepayments and accrued income
-
0
3,367
Intangible assets
-
638,292
Tangible assets
525
1,469
389,623
812,647
Deferred tax asset
-
0
30,377
389,623
843,024
5
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
-
0
1
Trade creditors
552
2,020
Amounts owed to group undertakings
-
0
1,770,803
Other creditors
7,625
223,244
8,177
1,996,068
6
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

TELUS HEALTH (BF) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
6
Audit report information
(Continued)
- 6 -
Opinion

In our opinion the financial statements:

Emphasis of matter – financial statements prepared on a basis other than a going concern

We draw attention to Note 1.2 to the financial statements which explains that the company ceased trading in May 2025 and therefore they do not consider it to be appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly the financial statements have been prepared on a basis other than going concern as described in Note 1.2.

 

Our opinion is not modified in respect of this matter.

Senior Statutory Auditor:
Alison Buckley
Statutory Auditor:
Mitchell Charlesworth
Date of audit report:
24 September 2026
TELUS HEALTH (BF) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
7
Related party transactions

At the year-end the company's ultimate parent company was Telus Corporation. The immediate parent company was Telus Health (UK) Holdco Limited, a company incorporated in England & Wales, which owns 100% of the company's issued share capital.

 

At the year-end the company had a receivable of £311,893 from Telus Health (UK) Limited (2024 - had a payable of £1,461,847).

 

At the year-end, the company owed Telus Health (US) Limited £Nil (2024 - £308,956).

2025-12-312025-01-01falsefalsefalse24 September 2026CCH SoftwareCCH Accounts Production 2026.200No description of principal activityMr P J MullenMr K J VallisBroughton Secretaries Limited074415222025-01-012025-12-31074415222025-12-3107441522core:WithinOneYear2025-12-3107441522core:WithinOneYear2024-12-31074415222024-12-3107441522core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3107441522core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3107441522core:ShareCapital2025-12-3107441522core:ShareCapital2024-12-3107441522core:SharePremium2025-12-3107441522core:SharePremium2024-12-3107441522core:RetainedEarningsAccumulatedLosses2025-12-3107441522core:RetainedEarningsAccumulatedLosses2024-12-3107441522bus:Director12025-01-012025-12-31074415222024-01-012024-12-3107441522core:CurrentFinancialInstruments2025-12-3107441522core:CurrentFinancialInstruments2024-12-3107441522bus:PrivateLimitedCompanyLtd2025-01-012025-12-3107441522bus:FRS1022025-01-012025-12-3107441522bus:Audited2025-01-012025-12-3107441522bus:Director22025-01-012025-12-3107441522bus:CompanySecretary12025-01-012025-12-3107441522bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3107441522bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP